(Q39416399)

11 September 2017

Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis (English)

1 reference

11 September 2017

endoplasmic reticulum

0 references

melatonin

0 references

hepatocellular carcinoma

1 reference

1 reference

Lixia Zha

1

1 reference

11 September 2017

Lulu Fan

2

1 reference

11 September 2017

Guoping Sun

3

1 reference

11 September 2017

Hua Wang

4

1 reference

11 September 2017

Tai Ma

5

1 reference

11 September 2017

Fei Zhong

6

1 reference

11 September 2017

Wei Wei

7

1 reference

11 September 2017

8 January 2012

1 reference

Journal of Pineal Research

11 September 2017

1 reference

11 September 2017

52

1 reference

11 September 2017

3

1 reference

11 September 2017

322-331

1 reference

Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Signal integration in the endoplasmic reticulum unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

The endoplasmic reticulum and the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Endoplasmic reticulum stress: cell life and death decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Orchestrating the unfolded protein response in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

The role of the unfolded protein response in tumour development: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

The melatonin rhythm: both a clock and a calendar

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Melatonin, circadian rhythms, and sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Basic mechanisms involved in the anti-cancer effects of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Melatonin sensitizes Caki renal cancer cells to kahweol-induced apoptosis through CHOP-mediated up-regulation of PUMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Estimating the world cancer burden: Globocan 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

New therapies for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

The development of pro-apoptotic cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Inhibition of MEK blocks GRP78 up-regulation and enhances apoptosis induced by ER stress in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Characterization of bortezomib-adapted I-45 mesothelioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Human melanoma cells under endoplasmic reticulum stress acquire resistance to microtubule-targeting drugs through XBP-1-mediated activation of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

The role of cyclooxygenases in inflammation, cancer, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Cyclooxygenase-2--10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Melatonin: pharmacological aspects and clinical trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Melatonin as a natural ally against oxidative stress: a physicochemical examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Molecular mechanisms of melatonin anticancer effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Melatonin as antioxidant, geroprotector and anticarcinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Blood pressure-lowering effect of melatonin in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

Clinical uses of melatonin: evaluation of human trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00946.X

10.1111/J.1600-079X.2011.00946.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference